Ignite Creation Date:
2024-05-06 @ 1:35 AM
Last Modification Date:
2024-10-26 @ 11:06 AM
Study NCT ID:
NCT01849523
Status:
COMPLETED
Last Update Posted:
2024-05-06
First Post:
2013-05-03
Brief Title:
Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor a Randomized Pilot Study
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Study Overview
Official Title:
Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor a Randomized Pilot Study Pilot WIN-study
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
WIN
Brief Summary:
Background Physical as well as psychosocial complaints are frequently present in patients with a neuroendocrine tumor NET Adequate information is seen as an essential aspect of supportive care The aim of the current study is to test the effectiveness of a web-based tailored information and support system targeting patients information and care needs Key features of this system are self-screening of physical and psychosocial problems tailored education on reported problems and self-referral to professional health care
Objective To detect whether a web-based tailored information and support system improves patients perception and satisfaction of received information The investigators hypothesize that after having received web-based tailored information and support patients feel more informed and are more satisfied with the received information than when receiving standard care
Study design The present study is a randomized prospective longitudinal experimental multicenter pilot study In this study we want to examine the effect sizes on the perception and satisfaction by the patient of received information primary objective and secondary objectives after having used web-based tailored information and support Eligible are newly diagnosed NET-patients N40 diagnosed less than 3 months ago Patients will be asked to fill out questionnaires at baseline and after 12 weeks on socio-demographic features only at baseline internet use only at baseline health care use patients perception and satisfaction of received information distress quality of life and empowerment only after 12 weeks
Study population Patients diagnosed with a NET any type of NET any phase of disease who are under treatment at the Department of Medical Oncology in the University Medical Center Groningen or Hospital Medisch Spectrum twenty will be invited to participate in the study
Intervention During 12 subsequent weeks a personalized website with a surnamepassword will become available to patients in the experimental group beside the usual standard care Key features of the website are self-screening tailored patient education and self-referral Self-screening will be performed by an online version of the Dutch Distress thermometer DT and Problem List PL Patients will receive automated feedback on their DT score immediately after test completion together with information regarding problems reported on the PL options for self-help and possibilities for referral to professional care Contact information will also be available to discuss questions problems andor referral needs Patients may also request a telephone call
Main study endpoint The primary endpoint is to detect an improvement in patients perception and satisfaction of received information after having received web-based tailored information and support
Objective To detect whether a web-based tailored information and support system improves patients perception and satisfaction of received information The investigators hypothesize that after having received web-based tailored information and support patients feel more informed and are more satisfied with the received information than when receiving standard care
Study design The present study is a randomized prospective longitudinal experimental multicenter pilot study In this study we want to examine the effect sizes on the perception and satisfaction by the patient of received information primary objective and secondary objectives after having used web-based tailored information and support Eligible are newly diagnosed NET-patients N40 diagnosed less than 3 months ago Patients will be asked to fill out questionnaires at baseline and after 12 weeks on socio-demographic features only at baseline internet use only at baseline health care use patients perception and satisfaction of received information distress quality of life and empowerment only after 12 weeks
Study population Patients diagnosed with a NET any type of NET any phase of disease who are under treatment at the Department of Medical Oncology in the University Medical Center Groningen or Hospital Medisch Spectrum twenty will be invited to participate in the study
Intervention During 12 subsequent weeks a personalized website with a surnamepassword will become available to patients in the experimental group beside the usual standard care Key features of the website are self-screening tailored patient education and self-referral Self-screening will be performed by an online version of the Dutch Distress thermometer DT and Problem List PL Patients will receive automated feedback on their DT score immediately after test completion together with information regarding problems reported on the PL options for self-help and possibilities for referral to professional care Contact information will also be available to discuss questions problems andor referral needs Patients may also request a telephone call
Main study endpoint The primary endpoint is to detect an improvement in patients perception and satisfaction of received information after having received web-based tailored information and support
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NL4383404213 | OTHER | ABR number CCMO | None |